Achieve Life Sciences Announces Initiation of ORCA-OL Clinical Trial Evaluating Long-Term Exposure of Cytisinicline in People who Smoke or Use Nicotine E-Cigarettes

SEATTLE and VANCOUVER, British Columbia, May 29, 2024 -- Achieve Life Sciences, Inc. , or Achieve, a late-stage pharmaceutical company committed to the global development and commercialization of...

Related Keywords

United States ,Geneva ,Genè ,Switzerland ,United Kingdom ,Vancouver ,British Columbia ,Canada ,British ,Cindy Jacobs ,Nicole Jones ,National Youth Tobacco ,Life Sciences ,Exchange Commission ,Drug Administration ,Human Services ,Nasdaq ,Globenewswire Inc ,Life Sciences Inc ,Us Department Of Health ,High School Students ,World Health Organization ,Health Consequences Of Smoking ,New Drug Application ,Chief Medical Officer ,Private Securities Litigation Reform Act ,Annual Reports ,Quarterly Reports ,Product Use Among Adults ,Mortal Wkly Rep ,Global Tobacco Epidemic ,Health Organization ,Health Consequences ,Surgeon General ,Youth Tobacco Survey ,